Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15262149 | 0.83 | — | — | |
| SCHEMBL1845751 | 0.83 | — | — | |
| SCHEMBL8855765 | 0.81 | PARP1 (0.31) | — | |
| SCHEMBL26015677 | 0.78 | BAZ2B (0.33) | CRHBPCRHR2 | |
| SCHEMBL12443797 | 0.78 | CRHBP (0.41) | CRHBPCRHR2 | |
| SCHEMBL9442011 | 0.77 | ALDH1A1 (0.43) | — | |
| SCHEMBL9789898 | 0.77 | — | — | |
| SCHEMBL16241310 | 0.76 | MAPT (0.31) | — | |
| SCHEMBL16774650 | 0.75 | — | — | |
| SCHEMBL18496198 | 0.72 | CRHBP (0.33) | CRHBPCRHR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5622944-A | MODIFIED 17-HYDROXY STEROL; TRANSDERMAL ELECTROTRANSPORT ENHANCEMENT | AFFYMAX TECHNOLOGIES N.V. (GB) | 1997-04-22 | — | — | US | claimed |
| JP-5194113-A | — | — | None | — | — | JP | disclosed |
| US-11020438-B2 | Phospholipid compositions and their preparation | AKER BIOMARINE ANTARCTIC AS (NO) | 2021-06-01 | — | — | US | disclosed |
| US-10960016-B2 | Capsules containing high doses of krill phospholipids | AKER BIOMARINE ANTARCTIC AS (NO) | 2021-03-30 | — | — | US | disclosed |
| EP-3094337-B1 | PHOSPHOLIPID COMPOSITIONS AND THEIR PREPARATION | AKER BIOMARINE ANTARCTIC AS (NO) | 2021-03-24 | — | — | EP | disclosed |
| US-10806742-B2 | Liquid phospholipid-containing compositions for the preparation of pharmaceuticals | AKER BIOMARINE ANTARCTIC AS (NO) | 2020-10-20 | — | — | US | disclosed |
| US-20200016214-A1 | PHOSPHOLIPID COMPOSITIONS AND THEIR PREPARATION | AKER BIOMARINE HUMAN INGREDIENTS AS (NO) | 2020-01-16 | — | — | US | disclosed |
| US-20180133263-A1 | PHOSPHOLIPID COMPOSITIONS AND THEIR PREPARATION | AKER BIOMARINE ANTARCTIC AS (NO) | 2018-05-17 | — | — | US | disclosed |
| US-9867856-B2 | Phospholipid compositions and their preparation | AKER BIOMARINE ANTARCTIC AS (NO) | 2018-01-16 | — | — | US | disclosed |
| US-20170182074-A1 | LIQUID PHOSPHOLIPID-CONTAINING COMPOSITIONS FOR THE PREPARATION OF PHARMACEUTICALS | AKER BIOMARINE HUMAN INGREDIENTS AS (NO) | 2017-06-29 | — | — | US | disclosed |
| WO-2015121381-A1 | CAPSULES CONTAINING HIGH DOSES OF KRILL PHOSPHOLIPIDS | AKER BIOMARINE ANTARCTIC AS (NO) | 2015-08-20 | — | — | WO | disclosed |
| WO-2015121378-A1 | LIQUID PHOSPHOLIPID-CONTAINING COMPOSITIONS FOR THE PREPARATION OF PHARMACEUTICALS | AKER BIOMARINE ANTARCTIC AS (NO) | 2015-08-20 | — | — | WO | disclosed |
| WO-2015104401-A1 | PHOSPHOLIPID COMPOSITIONS AND THEIR PREPARATION | AKER BIOMARINE ANTARCTIC AS (NO) | 2015-07-16 | — | — | WO | disclosed |
| EP-2114462-B1 | Compounds for fluorescence imaging | UNIV GENEVE (CH) | 2013-06-05 | — | — | EP | disclosed |
| US-20100278745-A1 | COMPOUNDS FOR FLUORESCENCE IMAGING | UNIVERSITE DE GENEVE (CH) | 2010-11-04 | — | — | US | disclosed |
| EP-2114462-A2 | COMPOUNDS FOR FLUORESCENCE IMAGING | UNIVERSITE DE GENEVE (CH) | 2009-11-11 | — | — | EP | disclosed |
| WO-2008078190-A2 | COMPOUNDS FOR FLUORESCENCE IMAGING | UNIVERSITE DE GENEVE (US) | 2008-07-03 | — | — | WO | disclosed |
| EP-1241522-A1 | Processing method for silver halide color photographic material | Fuji Photo Film Co., Ltd. (JP) | 2002-09-18 | — | — | EP | disclosed |
| US-5622944-A | MODIFIED 17-HYDROXY STEROL; TRANSDERMAL ELECTROTRANSPORT ENHANCEMENT | AFFYMAX TECHNOLOGIES N.V. (GB) | 1997-04-22 | — | — | US | disclosed |
| JP-H05194113-A | ANTIFOULING AGENT | KAIYO BIO TECHNOL KENKYUSHO:KK | 1993-08-03 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170182074-A1 | LIQUID PHOSPHOLIPID-CONTAINING COMPOSITIONS FOR THE PREPARATION OF PHARMACEUTICALS | PHOSPHO1, PLTP, LIPA | CRHBP 3028/4885CRHR2 4508/4885 |
| US-20200016214-A1 | PHOSPHOLIPID COMPOSITIONS AND THEIR PREPARATION | PHOSPHO1, PLTP, PLIN5 | CRHBP 2315/4885CRHR2 4675/4885 |
| US-20180133263-A1 | PHOSPHOLIPID COMPOSITIONS AND THEIR PREPARATION | PHOSPHO1, PLTP, PLIN5 | CRHBP 2315/4885CRHR2 4675/4885 |
| US-10806742-B2 | Liquid phospholipid-containing compositions for the preparation of pharmaceuticals | PHOSPHO1, PLTP, LIPA | CRHBP 3028/4885CRHR2 4508/4885 |
| US-11020438-B2 | Phospholipid compositions and their preparation | PHOSPHO1, PLTP, PLIN5 | CRHBP 2315/4885CRHR2 4675/4885 |
| US-10960016-B2 | Capsules containing high doses of krill phospholipids | PHOSPHO1, PLIN5, SGMS2 | CRHBP 1671/4885CRHR2 3479/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.